Exploring alternative financing models and early access schemes for orphan drugs: a Belgian case study

BACKGROUND: Although some jurisdictions have implemented particular adjustments to accommodate often-expensive orphan drugs in their healthcare systems, availability of these drugs remains complex. This study investigates alternative financing models and early access schemes for orphan drugs in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdallah, Khadidja, Claes, Kathleen, Huys, Isabelle, Follon, Lennert, Calis, Charlotte, Simoens, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733299/
https://www.ncbi.nlm.nih.gov/pubmed/36494733
http://dx.doi.org/10.1186/s13023-022-02571-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733299/
https://www.ncbi.nlm.nih.gov/pubmed/36494733
http://dx.doi.org/10.1186/s13023-022-02571-8

Ejemplares similares